Rezolute (RZLT) Cash & Equivalents (2010 - 2026)
Rezolute (RZLT) reported Cash & Equivalents of $10.62 million for fiscal Q4 2026 (quarter ended Jun 30, 2026), down 88.7% from $94.11 million a year earlier and down 5.5% from the prior quarter.
Powered by 
Analysis
Rezolute (RZLT) Cash & Equivalents (2010 - 2026) Analysis & Trends
Dating back to fiscal Q1 2011, Rezolute's Cash & Equivalents record includes 35 quarters.
- Cash & Equivalents has a five-year compound annual growth rate of -23.7% (FY2021 to FY2026).
- By fiscal year, Cash & Equivalents came in at $94.11 million in FY2025 (+33.7%), $70.4 million in FY2024 (+339.0%), $16.04 million in FY2023 (-89.3%) and $150.41 million in FY2022 (+266.4%).
- Five-year quarterly Cash & Equivalents spans a low of $5.93 million in fiscal Q3 2024 and a high of $154.32 million in fiscal Q1 2023.
- Year over year, Cash & Equivalents gained in four of the last eight quarters, with growth averaging 11.2%.
- The high point for year-over-year Cash & Equivalents in five years was fiscal Q1 2022 (growth of 482.4%); the low point was fiscal Q1 2024 (a decline of 94.8%).
- Per Business Quant data, the three fiscal quarters before Q4 2026 came in at $11.24 million (Q3 2026), $11.94 million (Q2 2026) and $9.1 million (Q1 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 20.42 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 4.89 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 976.00 Mn |
| 10 | Rezolute | 386.59 Mn | 386.59 Mn | - | 10.62 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 10.62 Mn |
| Mar 31, 2026 | 11.24 Mn |
| Dec 31, 2025 | 11.94 Mn |
| Sep 30, 2025 | 9.10 Mn |
| Jun 30, 2025 | 94.11 Mn |
| Mar 31, 2025 | 14.60 Mn |
| Dec 31, 2024 | 8.93 Mn |
| Sep 30, 2024 | 10.50 Mn |
| Jun 30, 2024 | 70.40 Mn |
| Mar 31, 2024 | 5.93 Mn |
| Dec 31, 2023 | 12.50 Mn |
| Sep 30, 2023 | 8.10 Mn |
| Jun 30, 2023 | 16.04 Mn |
| Mar 31, 2023 | 33.74 Mn |
| Dec 31, 2022 | 146.75 Mn |
| Sep 30, 2022 | 154.32 Mn |
| Jun 30, 2022 | 150.41 Mn |
| Mar 31, 2022 | 63.42 Mn |
| Dec 31, 2021 | 77.40 Mn |
| Sep 30, 2021 | 37.30 Mn |
API Access
Rezolute Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=RZLT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "RZLT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=RZLT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();